PRME is currently covered by 4 analysts with an average price target of $8. This is a potential upside of $4.45 (125.35%) from yesterday's end of day stock price of $3.55.
Prime Medicine's activity chart (see below) currently has 55 price targets and 54 ratings on display. The stock rating distribution of PRME is 87.5% BUY and 12.5% HOLD.
Analysts' price targets on this stock were met 18.75% of the time, taking 48.33 days on average.
Highest price target for PRME is $11, Lowest price target is $6, average price target is $8.
Most recent stock forecast was given by ARTHUR HE from HC WAINWRIGHT. First documented stock forecast 14-Nov-2022.
Currently out of the existing stock ratings of PRME, 7 are a BUY (87.5%), 1 are a HOLD (12.5%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Aug-2026
$8
$4.45 (125.35%)
$8
6 days ago
(16-Nov-2026)
Buy Since 25-Aug-2026
$7
$3.45 (97.18%)
$7
1 months 28 days ago
(25-Sep-2026)
0/2 (0%)
$4.1 (141.38%)
Buy Since 10-Dec-2024
$6
$2.45 (69.01%)
$6
5 months ago
(22-Jun-2026)
2/6 (33.33%)
$2.63 (78.04%)
121
Buy Since 09-Oct-2023
$11
$7.45 (209.86%)
$10
8 months 10 days ago
(12-Mar-2026)
0/5 (0%)
$7.27 (194.91%)
Hold Since 11-Nov-2025
$4.25
1 years 11 days ago
(11-Nov-2025)
1/4 (25%)
$0.33 (8.42%)
29
What is PRME (Prime Medicine) average time for price targets to be met?
Which analyst most recently updated their price target on PRME (Prime Medicine)?
Which analyst has the most public recommendations on PRME (Prime Medicine)?
Which analyst is the currently most bullish on PRME (Prime Medicine)?
Which analyst is the currently most reserved on PRME (Prime Medicine)?